Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01084954 · ClinicalTrials.gov registry record
Validation of a Simple and Cost-Effective Nucleic Acid Test for HIV Detection
A clinical trial, sponsored by George Washington University.
- Completed
- Registry status
- 153
- Enrollment target
NCT01084954: Completed study, sponsored by George Washington University.
NCT01084954 is a clinical trial that has completed, run by George Washington University. The registered enrollment target is 153 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01084954 has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- 153 participants
- Enrollment target
Study Summary
Validate a simple and cost-effective Nucleic Acid Test for HIV Detection in order to develop a rapid, highly sensitive and specific, one-stage test for the diagnosis of HIV infection. Blood samples collected will be assayed using the BioHelix Corporation helicase-dependent amplification or the Cepheid Xpert HIV-1 Quant Assay. A false negative or false positive rate of \>1.0% would make this test unacceptable as a screening test for HIV viremia.
Primary Outcome
A false negative or false positive rate of \> 1.0% would make this test unacceptable as a screening test for HIV viremia.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2009-03 |
| Est. Completion | 2016-04 |
What the finished NCT01084954 record still lists
NCT01084954 is an observational study that tracks outcomes without assigning an intervention. The registered 153 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01084954 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01084954 about?
NCT01084954 is a clinical study titled "Validation of a Simple and Cost-Effective Nucleic Acid Test for HIV Detection". Validate a simple and cost-effective Nucleic Acid Test for HIV Detection in order to develop a rapid, highly sensitive and specific, one-stage test for the diagnosis of HIV infection. Blood samples collected will be assayed using the BioHelix Corporation helicase-dependent amplification or the Cephe...
What is the current status of trial NCT01084954?
This trial is currently completed. The enrollment target is 153 participants. The study started on 2009-03. Estimated completion is 2016-04.
Who is sponsoring clinical trial NCT01084954?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05283265 · 153 participants · NA
Neurophysiological Mechanisms of Language Comprehension
- NCT05554393 · 153 participants · Phase 2
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
- NCT05584501 · 153 participants · NA
ETE Interventions in the Dental Setting
- NCT05714839 · 153 participants · Phase 1
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia